Imagine if GWPH had access to InMed’s proprietary cannabinoid biosynthesis technology now. I can only imagine how high the current costs are for GWPH to get the cannabinoids they require for the drug process.
I bet company restructures closer to product hitting market. This company has so much more going for them imho - in terms of potential and what they're working with. Their portfolio of patents is amazing. Their management, etc. I really couldn't of see them being much bigger than he pharmaceuticals. It's a stretch but I can see it. This stock will require patience. A lot of it.
News 
Market Data 
Discover 
